{
  "context": {
    "rules": [
      "Rule1: If a safety audit is initiated for Drug Alpha in Region Alpha, then, provided that it is not the case that if Drug Alpha fails safety in Region Alpha then it does not pass safety in Region Alpha, Drug Alpha is subject to market recall in Region Alpha.",
      "Rule2: Either a safety audit is initiated for Drug Alpha in Region Alpha, or a regulatory review is initiated for Drug Alpha in Region Alpha.",
      "Rule3: Under the condition that Drug Alpha has priority in Region Alpha, if a regulatory review is initiated for Drug Alpha in Region Alpha, then, given that it is not the case that if Drug Alpha fails safety in Region Alpha then it does not pass safety in Region Alpha, Drug Alpha is subject to market recall in Region Alpha.",
      "Rule4: If Drug Alpha receives quick approval in Region Alpha, then Drug Alpha is available in the market in Region Alpha.",
      "Rule5: Drug Alpha receives quick approval in Region Alpha, or Drug Alpha receives standard approval in Region Alpha.",
      "Rule6: If approval for Drug Alpha is granted in Region Alpha, then, under the condition that it is not the case that if Drug Alpha receives standard approval in Region Alpha then Drug Alpha is available in the market in Region Alpha, approval for Drug Alpha is not delayed in Region Alpha.",
      "Rule7: If Drug Alpha is authorized for emergency use in Region Alpha, then Drug Alpha is authorized for compassionate use in Region Alpha.",
      "Rule8: If Drug Alpha is banned in Region Alpha, then it is not the case that Drug Alpha is approved in Region Alpha.",
      "Rule9: Provided that safety of Drug Alpha is proven in Region Alpha, Drug Alpha is available in the market in Region Alpha.",
      "Rule10: If Drug Alpha is in a fast track process in Region Alpha, then, given that it is not the case that if efficacy of Drug Alpha is proven in Region Alpha then safety of Drug Alpha is proven in Region Alpha, additional testing is required for Drug Alpha in Region Alpha.",
      "Rule11: Provided that Drug Alpha is in a normal process in Region Alpha, whenever it is not the case that if efficacy of Drug Alpha is proven in Region Alpha then safety of Drug Alpha is proven in Region Alpha, additional testing is required for Drug Alpha in Region Alpha.",
      "Rule12: The process for Drug Alpha is complete in Region Alpha, or Drug Alpha is in a fast track process in Region Alpha, or Drug Alpha is in a normal process in Region Alpha.",
      "Rule13: If the process for Drug Alpha is suspended in Region Alpha, then it is not the case that the process for Drug Alpha is complete in Region Alpha.",
      "Rule14: If the ban on Drug Alpha is appealed in Region Alpha, then, under the condition that Drug Alpha is under reconsideration in Region Alpha, it is not the case that Drug Alpha is approved in Region Alpha.",
      "Rule15: If Drug Alpha requires clinical trial skill, then Drug Alpha requires safety legislation.",
      "Rule16: Provided that the ban on Drug Alpha is overturned in Region Alpha, it is not the case that the ban on Drug Alpha is upheld in Region Alpha.",
      "Rule17: If Drug Alpha is legally manufactured in Region Alpha, then it is not the case that Drug Alpha is illegally manufactured in Region Alpha.",
      "Rule18: Provided that Drug Alpha is under investigation in Region Alpha, Drug Alpha passes safety in Region Alpha.",
      "Rule19: If Drug Alpha is under investigation in Region Alpha, then Drug Alpha fails safety in Region Alpha.",
      "Rule20: Under the condition that it is not the case that if Drug Alpha receives standard approval in Region Alpha then Drug Alpha is available in the market in Region Alpha, approval for Drug Alpha is delayed in Region Alpha.",
      "Rule21: If it is not the case that if Drug Alpha is authorized for compassionate use in Region Alpha then approval for Drug Alpha is granted in Region Alpha, then use of Drug Alpha is restricted in Region Alpha.",
      "Rule22: Whenever it is not the case that if Drug Alpha is authorized for compassionate use in Region Alpha then approval for Drug Alpha is granted in Region Alpha, it is not the case that use of Drug Alpha is restricted in Region Alpha.",
      "Rule23: If it is not the case that if efficacy of Drug Alpha is proven in Region Alpha then safety of Drug Alpha is proven in Region Alpha, then it is not the case that additional testing is required for Drug Alpha in Region Alpha.",
      "Rule24: Under the condition that it is not the case that if Drug Alpha requires safety legislation then Drug Alpha is banned in Region Alpha, Drug Alpha is illegally manufactured in Region Alpha.",
      "Rule25: Whenever it is not the case that if Drug Alpha requires safety legislation then Drug Alpha is banned in Region Alpha, Drug Alpha is legally manufactured in Region Alpha.",
      "Rule26: Under the condition that it is not the case that the ban on Drug Alpha is appealed in Region Alpha, the ban on Drug Alpha is upheld in Region Alpha.",
      "Rule27: Provided that it is not the case that Drug Alpha is available in the market in Region Alpha, Drug Alpha is approved in Region Alpha.",
      "Rule28: Whenever it is not the case that Drug Alpha is available in the market in Region Alpha, Drug Alpha is under reconsideration in Region Alpha.",
      "Rule29: Under the condition that it is not the case that Drug Alpha is available in the market in Region Alpha, Drug Alpha requires clinical trial skill.",
      "Rule30: Provided that it is not the case that Drug Alpha is available in the market in Region Alpha, Drug Alpha is under investigation in Region Alpha."
    ],
    "facts": [
      "Fact1: Drug Alpha has priority in Region Alpha.",
      "Fact2: Drug Alpha is authorized for emergency use in Region Alpha.",
      "Fact3: Efficacy of Drug Alpha is proven in Region Alpha.",
      "Fact4: The process for Drug Alpha is suspended in Region Alpha.",
      "Fact5: The ban on Drug Alpha is overturned in Region Alpha.",
      "Fact6: It is not the case that Drug Alpha is subject to market recall in Region Alpha."
    ]
  },
  "question": "Drug Alpha is available in the market in Region Alpha."
}